Sofosbuvir for the treatment of hepatitis C virus infection.
作者信息
Rolland Sébastien, Vachon Marie-Louise
机构信息
Department of Medicine (Rolland), Division of Infectious Diseases (Vachon), Université Laval, Québec City, Que.
出版信息
CMAJ. 2015 Feb 17;187(3):203-204. doi: 10.1503/cmaj.140151. Epub 2014 Jul 7.
Abstract
摘要
相似文献
1
Sofosbuvir for the treatment of hepatitis C virus infection.索非布韦用于治疗丙型肝炎病毒感染。
CMAJ. 2015 Feb 17;187(3):203-204. doi: 10.1503/cmaj.140151. Epub 2014 Jul 7.
2
Mutant Ninja viruses.变异忍者病毒。
Hepatology. 2015 Feb;61(2):421-3. doi: 10.1002/hep.27540. Epub 2015 Jan 5.
3
Sofosbuvir (Sovaldi) for hepatitis C virus.
Nurse Pract. 2015 Sep 13;40(9):16-9. doi: 10.1097/01.NPR.0000470360.31332.54.
4
Quantum leaps, microeconomics, and the treatment of patients with hepatitis C and HIV coinfection.量子跃迁、微观经济学与丙型肝炎和艾滋病毒合并感染患者的治疗
JAMA. 2014;312(4):347-8. doi: 10.1001/jama.2014.7735.
5
[Hepatitis C genotype 1. Harvoni and Holkira Pak reimbursed?].[丙型肝炎基因1型。Harvoni和Holkira Pak是否已报销？]
Perspect Infirm. 2015 Nov-Dec;12(5):60.
6
New concepts of sofosbuvir-based treatment regimens in patients with hepatitis C.丙型肝炎患者基于索磷布韦治疗方案的新概念
Gut. 2014 Feb;63(2):207-15. doi: 10.1136/gutjnl-2013-305771. Epub 2013 Nov 19.
7
Two Antiviral Drugs Approved For Adolescents With HCV.两种抗病毒药物被批准用于治疗丙型肝炎病毒感染的青少年。
Am J Nurs. 2017 Aug;117(8):22. doi: 10.1097/01.NAJ.0000521968.08223.4f.
8
Sofosbuvir/ledipasvir as treatment of hepatitis C virus genotype 5 infection: Two case reports.索磷布韦/来迪帕司韦治疗丙型肝炎病毒5型感染：两例病例报告。
Med Clin (Barc). 2018 Jul 23;151(2):85-86. doi: 10.1016/j.medcli.2017.10.041. Epub 2017 Dec 30.
9
Hepatitis C and HIV co-infection: closing the gaps.丙型肝炎与艾滋病毒合并感染：消除差距。
JAMA. 2015;313(12):1217-8. doi: 10.1001/jama.2015.1111.
10
Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients.索磷布韦、西米普明和利巴韦林用于治疗人类免疫缺陷病毒/丙型肝炎病毒合并感染的肝移植受者中的丙型肝炎病毒复发。
Liver Transpl. 2015 Feb;21(2):272-4. doi: 10.1002/lt.24027.
引用本文的文献
1
Efficacy of 8-week daclatasvir-sofosbuvir regimen in chronic hepatitis C: a systematic review and meta-analysis.8 周达卡他韦-索磷布韦方案治疗慢性丙型肝炎的疗效：系统评价和荟萃分析。
Virol J. 2024 Nov 4;21(1):275. doi: 10.1186/s12985-024-02544-2.
2
Identification of NS5B Resistance-Associated Mutations in Hepatitis C Virus Circulating in Treatment Naïve Vietnamese Patients.越南初治患者中丙型肝炎病毒NS5B耐药相关突变的鉴定
Infect Drug Resist. 2022 Apr 5;15:1547-1554. doi: 10.2147/IDR.S353605. eCollection 2022.
3
Combating Human Viral Diseases: Will Plant-Based Vaccines Be the Answer?对抗人类病毒性疾病：植物源疫苗会是答案吗？
Vaccines (Basel). 2021 Jul 8;9(7):761. doi: 10.3390/vaccines9070761.
本文引用的文献
1
Sofosbuvir and ribavirin in HCV genotypes 2 and 3.索磷布韦和利巴韦林治疗 2 型和 3 型丙型肝炎病毒。
N Engl J Med. 2014 May 22;370(21):1993-2001. doi: 10.1056/NEJMoa1316145. Epub 2014 May 4.
2
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.来迪派韦索磷布韦片与索磷布韦联用治疗初治的 HCV 基因 1 型感染。
N Engl J Med. 2014 May 15;370(20):1889-98. doi: 10.1056/NEJMoa1402454. Epub 2014 Apr 11.
3
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.来迪派韦索磷布韦片治疗既往治疗的 HCV 基因 1 型感染。
N Engl J Med. 2014 Apr 17;370(16):1483-93. doi: 10.1056/NEJMoa1316366. Epub 2014 Apr 11.
4
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.聚乙二醇干扰素α-2a 联合利巴韦林治疗慢性丙型肝炎
N Engl J Med. 2014 May 15;370(20):1879-88. doi: 10.1056/NEJMoa1402355. Epub 2014 Apr 10.
5
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.达卡他韦联合索非布韦治疗既往治疗或未经治疗的慢性 HCV 感染。
N Engl J Med. 2014 Jan 16;370(3):211-21. doi: 10.1056/NEJMoa1306218.
6
Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial.索磷布韦和来迪派韦固定剂量复方与利巴韦林联合或不联合用于初治和经治的基因 1 型丙型肝炎病毒感染患者（LONESTAR）：一项开放标签、随机、2 期临床试验。
Lancet. 2014 Feb 8;383(9916):515-23. doi: 10.1016/S0140-6736(13)62121-2. Epub 2013 Nov 5.
7
Sofosbuvir for previously untreated chronic hepatitis C infection.索磷布韦片治疗未经治疗的慢性丙型肝炎感染。
N Engl J Med. 2013 May 16;368(20):1878-87. doi: 10.1056/NEJMoa1214853. Epub 2013 Apr 23.
8
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options.索磷布韦用于无治疗选择的 2 或 3 型丙型肝炎病毒感染患者。
N Engl J Med. 2013 May 16;368(20):1867-77. doi: 10.1056/NEJMoa1214854. Epub 2013 Apr 23.
9
Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.核苷酸聚合酶抑制剂索非布韦联合利巴韦林治疗丙型肝炎。
N Engl J Med. 2013 Jan 3;368(1):34-44. doi: 10.1056/NEJMoa1208953.
10
Telaprevir for previously untreated chronic hepatitis C virus infection.替拉瑞韦治疗初治慢性丙型肝炎病毒感染。
N Engl J Med. 2011 Jun 23;364(25):2405-16. doi: 10.1056/NEJMoa1012912.
Zotero 插件